Skip to main content

Quality of Care Indicators for Radical Cystectomy

  • Chapter
  • First Online:
Bladder Cancer

Part of the book series: Current Clinical Urology ((CCU))

Abstract

Radical cystectomy is the gold standard treatment for invasive bladder cancer, and requires high standards for both surgical skill and ancillary support to achieve consistently good outcomes. As is the case elsewhere in the health care system, increasing attention has been paid in recent years to the quality of care delivered before, during, and after surgery. Defining high-quality care in the context of cystectomy, however, is far from straightforward. Multiple outcomes are relevant – perioperative morbidity and mortality, long-term oncologic outcomes, and urinary and sexual health-related quality of life – as there exists as yet no consensus on the best way to measure these outcomes and appropriately risk-adjust them based on patient case mix.

The process of identification and validation of structural aspects of care and processes of care which are likely to predict good outcomes is in an early stage for cystectomy. Several candidate measures have been examined, and each is controversial to some extent with respect to its relevance to cystectomy outcomes. The time from diagnosis to cystectomy, adequacy of lymphadenectomy, and availability of orthotopic diversion are three process measures which are good candidate indicators of quality care. Surgical volume, both surgeon- and hospital-specific, has received a great deal of attention in the media, but results of the studies to date must be interpreted cautiously, and the implications of policies implicitly or explicitly driving regionalization of cystectomy care should be carefully considered. It is critical that clinicians specializing in the care of bladder cancer, rather than regulators or insurers, continue to direct progress in forging consensus on approaches to measurement and reporting of quality outcomes for radical is in an early stage for cystectomy.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Taub DA, Dunn RL, Miller DC, Wei JT, Hollenbeck BK. Discharge practice patterns following cystectomy for bladder cancer: evidence for the shifting of the burden of care. J Urol 2006;176(6):2612–8.

    Article  PubMed  Google Scholar 

  2. Donabedian A. Evaluating the quality of medical care. The Milbank Mem Fund Q 1966;44(3S):166–206.

    Article  Google Scholar 

  3. Brook RH, McGlynn EA, Cleary PD. Quality of health care, part 2: Measuring quality of care. N Engl J Med 1996;335(13):966–70.

    Article  CAS  PubMed  Google Scholar 

  4. Eddy DM. Performance measurement: problems and solutions. Health Aff (Millwood) 1998;17(4):7–25.

    Article  CAS  Google Scholar 

  5. Gagliardi AR, Fleshner N, Langer B, Stern H, Brown AD. Development of prostate cancer quality indicators: a modified Delphi approach. Can J Urol 2005;12(5):2808–15.

    PubMed  Google Scholar 

  6. Spencer BA, Steinberg M, Malin J, Adams J, Litwin MS. Quality-of-care indicators for early-stage prostate cancer. J Clin Oncol 2003;21(10):1928–36.

    Article  PubMed  Google Scholar 

  7. Luft HS, Bunker JP, Enthoven AC. Should operations be regionalized? The empirical relation between surgical volume and mortality. N Engl J Med 1979;301(25):1364–9.

    Article  CAS  PubMed  Google Scholar 

  8. Halm EA, Lee C, Chassin MR. Is volume related to outcome in health care? A systematic review and methodologic critique of the literature. Ann Intern Med 2002;137(6):511–20.

    PubMed  Google Scholar 

  9. Dudley RA, Johansen KL, Brand R, Rennie DJ, Milstein A. Selective referral to high-volume hospitals: estimating potentially avoidable deaths. JAMA 2000;283(9):1159–66.

    Article  CAS  PubMed  Google Scholar 

  10. Begg CB, Cramer LD, Hoskins WJ, Brennan MF. Impact of hospital volume on operative mortality for major cancer surgery. JAMA 1998;280(20):1747–51.

    Article  CAS  PubMed  Google Scholar 

  11. Joudi FN, Konety BR. The impact of provider volume on outcomes from urological cancer therapy. J Urol 2005;174(2):432–8.

    Article  PubMed  Google Scholar 

  12. Galvin RS, Delbanco S, Milstein A, Belden G. Has the leapfrog group had an impact on the health care market? Health Aff (Millwood) 2005;24(1):228–33.

    Article  Google Scholar 

  13. Centers for Medicare & Medicaid Services. Medicare expands national coverage for bariatric surgery procedures. 2006. (Accessed Dec 2, 2006, at http://www.cms.hhs.gov/apps/media/press/release.asp?Counter = 1786.)

  14. Birkmeyer JD, Siewers AE, Finlayson EV, et al. Hospital volume and surgical mortality in the United States. N Engl J Med 2002;346(15):1128–37.

    Article  PubMed  Google Scholar 

  15. Birkmeyer JD, Stukel TA, Siewers AE, Goodney PP, Wennberg DE, Lucas FL. Surgeon volume and operative mortality in the United States. N Engl J Med 2003;349(22):2117–27.

    Article  CAS  PubMed  Google Scholar 

  16. Konety BR, Dhawan V, Allareddy V, Joslyn SA. Impact of hospital and surgeon volume on in-hospital mortality from radical cystectomy: data from the health care utilization project. J Urol 2005;173(5):1695–700.

    Article  PubMed  Google Scholar 

  17. Konety BR, Allareddy V, Herr H. Complications after radical cystectomy: analysis of population-based data. Urology 2006;68(1):58–64.

    Article  PubMed  Google Scholar 

  18. Konety BR, Dhawan V, Allareddy V, O'Donnell MA. Association between volume and charges for most frequently performed ambulatory and nonambulatory surgery for bladder cancer. Is more cheaper? J Urol 2004;172(3):1056–61.

    Google Scholar 

  19. Konety BR, Allareddy V, Modak S, Smith B. Mortality after major surgery for urologic cancers in specialized urology hospitals: are they any better? J Clin Oncol 2006;24(13):2006–12.

    Article  PubMed  Google Scholar 

  20. Elting LS, Pettaway C, Bekele BN, et al. Correlation between annual volume of cystectomy, professional staffing, and outcomes: a statewide, population-based study. Cancer 2005;104(5):975–84.

    Article  PubMed  Google Scholar 

  21. Welke KF, Barnett MJ, Sarrazin MS, Rosenthal GE. Limitations of hospital volume as a measure of quality of care for coronary artery bypass graft surgery. Ann Thorac Surg 2005;80(6):2114–9.

    Article  PubMed  Google Scholar 

  22. Ward MM, Jaana M, Wakefield DS, et al What would be the effect of referral to high-volume hospitals in a largely rural state? J Rural Health 2004;20(4):344–54.

    Article  PubMed  Google Scholar 

  23. Dimick JB, Finlayson SR, Birkmeyer JD. Regional availability of high-volume hospitals for major surgery. Health Aff (Millwood) 2004:Suppl Web Exclusive: VAR45–53.

    Google Scholar 

  24. Khuri SF, Henderson WG. The case against volume as a measure of quality of surgical care. World J Surg 2005;29(10):1222–9.

    Article  PubMed  Google Scholar 

  25. Best WR, Khuri SF, Phelan M, et al. Identifying patient preoperative risk factors and postoperative adverse events in administrative databases: results from the Department of Veterans Affairs National Surgical Quality Improvement Program. J Am Coll Surg 2002;194(3):257–66.

    Article  PubMed  Google Scholar 

  26. Modak S, Konety BR. Where are patients with major urologic cancers undergoing surgery? Changing trends in delivery of surgical and non-surgical care. J Urol 2006:Abstract 174.

    Google Scholar 

  27. Liu JH, Zingmond DS, McGory ML, et al. Disparities in the utilization of high-volume hospitals for complex surgery. JAMA 2006;296(16):1973–80.

    Article  CAS  PubMed  Google Scholar 

  28. Allareddy V, Konety BR. Race and outcome following radical cystectomy: the effect of hospital volume. J Urol 2006:Abstract 24.

    Google Scholar 

  29. Chang SS, Hassan JM, Cookson MS, Wells N, Smith JA, Jr. Delaying radical cystectomy for muscle invasive bladder cancer results in worse pathological stage. J Urol 2003;170(4 Pt 1):1085–7.

    Article  PubMed  Google Scholar 

  30. Sanchez-Ortiz RF, Huang WC, Mick R, Van Arsdalen KN, Wein AJ, Malkowicz SB. An interval longer than 12 weeks between the diagnosis of muscle invasion and cystectomy is associated with worse outcome in bladder carcinoma. J Urol 2003;169(1):110–5; discussion 5.

    Article  PubMed  Google Scholar 

  31. May M, Nitzke T, Helke C, Vogler H, Hoschke B. Significance of the time period between diagnosis of muscle invasion and radical cystectomy with regard to the prognosis of transitional cell carcinoma of the urothelium in the bladder. Scand J Urol Nephrol 2004;38(3):231–5.

    Article  CAS  PubMed  Google Scholar 

  32. Mahmud SM, Fong B, Fahmy N, Tanguay S, Aprikian AG. Effect of preoperative delay on survival in patients with bladder cancer undergoing cystectomy in Quebec: a population based study. J Urol 2006;175(1):78–83; discussion.

    Article  PubMed  Google Scholar 

  33. Honma I, Masumori N, Sato E, et al. Removal of more lymph nodes may provide better outcome, as well as more accurate pathologic findings, in patients with bladder cancer–analysis of role of pelvic lymph node dissection. Urology 2006;68(3):543–8.

    Article  PubMed  Google Scholar 

  34. Koppie TM, Vickers AJ, Vora K, Dalbagni G, Bochner BH. Standardization of pelvic lymphadenectomy performed at radical cystectomy: can we establish a minimum number of lymph nodes that should be removed? Cancer 2006;107(10):2368–74.

    Article  PubMed  Google Scholar 

  35. Bochner BH, Herr HW, Reuter VE. Impact of separate versus en bloc pelvic lymph node dissection on the number of lymph nodes retrieved in cystectomy specimens. J Urol 2001;166(6):2295–6.

    Article  CAS  PubMed  Google Scholar 

  36. Herr HW, Faulkner JR, Grossman HB, et al. Surgical factors influence bladder cancer outcomes: a cooperative group report. J Clin Oncol 2004;22(14):2781–9.

    Article  PubMed  Google Scholar 

  37. Konety BR, Joslyn SA, O'Donnell MA. Extent of pelvic lymphadenectomy and its impact on outcome in patients diagnosed with bladder cancer: analysis of data from the Surveillance, Epidemiology and End Results Program data base. J Urol 2003;169(3):946–50.

    Article  PubMed  Google Scholar 

  38. Gore JL, Saigal CS, Hanley JM, Schonlau M, Litwin MS. Variations in reconstruction after radical cystectomy. Cancer 2006;107(4):729–37.

    Article  PubMed  Google Scholar 

  39. Konety BR, Joyce GF, Wise M. Urologic Diseases in America: Bladder and upper tract urothelial cancer. J Urol 2007;177:1636–45.

    Article  PubMed  Google Scholar 

  40. Hollenbeck BK, Miller DC, Taub D, et al. Identifying risk factors for potentially avoidable complications following radical cystectomy. J Urol 2005;174(4 Pt 1):1231–7; discussion 7.

    Article  PubMed  Google Scholar 

  41. Hollenbeck BK, Miller DC, Taub DA, et al. The effects of adjusting for case mix on mortality and length of stay following radical cystectomy. J Urol 2006;176(4 Pt 1):1363–8.

    Article  PubMed  Google Scholar 

  42. Chang SS, Jacobs B, Wells N, Smith JA, Jr., Cookson MS. Increased body mass index predicts increased blood loss during radical cystectomy. J Urol 2004;171(3):1077–9.

    Article  PubMed  Google Scholar 

  43. Lee CT, Dunn RL, Chen BT, Joshi DP, Sheffield J, Montie JE. Impact of body mass index on radical cystectomy. J Urol 2004;172(4 Pt 1):1281–5.

    Article  PubMed  Google Scholar 

  44. Litwin MS, Lubeck DP, Henning JM, Carroll PR. Differences in urologist and patient assessments of health related quality of life in men with prostate cancer: results of the CaPSURE database. J Urol 1998;159(6):1988–92.

    Article  CAS  PubMed  Google Scholar 

  45. Cookson MS, Dutta SC, Chang SS, Clark T, Smith JA, Jr., Wells N. Health related quality of life in patients treated with radical cystectomy and urinary diversion for urothelial carcinoma of the bladder: development and validation of a new disease specific questionnaire. J Urol 2003;170(5):1926–30.

    Article  PubMed  Google Scholar 

  46. Gilbert SM, Wood DP, Weizer A, et al. Measuring health-related quality of life outcomes in bladder cancer patients using the newly validated Bladder Cancer Index (BCI). J Urol 2006;176(4 Pt 2):Abstract 36.

    Google Scholar 

  47. Mansson A, Davidsson T, Hunt S, Mansson W. The quality of life in men after radical cystectomy with a continent cutaneous diversion or orthotopic bladder substitution: is there a difference? BJU international 2002;90(4):386–90.

    Article  CAS  PubMed  Google Scholar 

  48. Botteman MF, Pashos CL, Hauser RS, Laskin BL, Redaelli A. Quality of life aspects of bladder cancer: a review of the literature. Qual Life Res 2003;12(6):675–88.

    Article  CAS  PubMed  Google Scholar 

  49. Gerharz EW, Mansson A, Hunt S, Skinner EC, Mansson W. Quality of life after cystectomy and urinary diversion: an evidence based analysis. J Urol 2005;174(5):1729–36.

    Article  PubMed  Google Scholar 

  50. Hart S, Skinner EC, Meyerowitz BE, Boyd S, Lieskovsky G, Skinner DG. Quality of life after radical cystectomy for bladder cancer in patients with an ileal conduit, cutaneous or urethral kock pouch. J Urol 1999;162(1):77–81.

    Article  CAS  PubMed  Google Scholar 

  51. Fujisawa M, Isotani S, Gotoh A, Okada H, Arakawa S, Kamidono S. Health-related quality of life with orthotopic neobladder versus ileal conduit according to the SF-36 survey. Urology 2000;55(6):862–5.

    Article  CAS  PubMed  Google Scholar 

  52. Hara I, Miyake H, Hara S, et al. Health-related quality of life after radical cystectomy for bladder cancer: a comparison of ileal conduit and orthotopic bladder replacement. BJU international 2002;89(1):10–3.

    Article  CAS  PubMed  Google Scholar 

  53. Allareddy V, Kennedy J, West MM, Konety BR. Quality of life in long-term survivors of bladder cancer. Cancer 2006;106(11):2355–62.

    Article  PubMed  Google Scholar 

  54. Hobisch A, Tosun K, Kinzl J, et al. Quality of life after cystectomy and orthotopic neobladder versus ileal conduit urinary diversion. World J Urol 2000;18(5):338–44.

    Article  CAS  PubMed  Google Scholar 

  55. Dutta SC, Chang SC, Coffey CS, Smith JA, Jr., Jack G, Cookson MS. Health related quality of life assessment after radical cystectomy: comparison of ileal conduit with continent orthotopic neobladder. J Urol 2002;168(1):164–7.

    Article  PubMed  Google Scholar 

  56. Dimick JB, Weeks WB, Karia RJ, Das S, Campbell DA, Jr. Who pays for poor surgical quality? Building a business case for quality improvement. J Am Coll Surg 2006;202(6):933–7.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Badrinath R. Konety .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Humana Press, a part of Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Cooperberg, M.R., Konety, B.R. (2009). Quality of Care Indicators for Radical Cystectomy. In: Lee, C., Wood, D. (eds) Bladder Cancer. Current Clinical Urology. Humana Press. https://doi.org/10.1007/978-1-59745-417-9_18

Download citation

  • DOI: https://doi.org/10.1007/978-1-59745-417-9_18

  • Published:

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-58829-988-8

  • Online ISBN: 978-1-59745-417-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics